Comparison of median survival duration of AML, AML with prior MDS, and RAEB-T and the treated subgroups
| . | All AML . | AML/prior MDS . | RAEB-T . | P (AML vs RAEB-T) . | P (AML/MDS vs RAEB-T) . |
|---|---|---|---|---|---|
| N | 448 | 138 | 51 | ||
| Surv (all, mo) | 6 | 6 | 9 | NS | <.01 |
| Treated, n (%) | 258 (58) | 52 (38) | 16 (31) | ||
| Surv (treated, mo) | 11 | 8 | 11 | NS | NS |
| . | All AML . | AML/prior MDS . | RAEB-T . | P (AML vs RAEB-T) . | P (AML/MDS vs RAEB-T) . |
|---|---|---|---|---|---|
| N | 448 | 138 | 51 | ||
| Surv (all, mo) | 6 | 6 | 9 | NS | <.01 |
| Treated, n (%) | 258 (58) | 52 (38) | 16 (31) | ||
| Surv (treated, mo) | 11 | 8 | 11 | NS | NS |
Surv, survival duration; NS, not significant.